{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:02:55Z","timestamp":1794088975778,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Data are limited regarding the combined impact of headache frequency and failure of preventive medication (efficacy and\/or tolerability) on the humanistic\/economic burden of migraine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective, cross-sectional analysis of 2020 National Health and Wellness Survey (NHWS) data was conducted. An opt-in online survey identified adults in France, Germany, Italy, Spain, and United Kingdom with self-reported physician-diagnosed migraine. Participants with\u2009\u2265\u20094 monthly headache days (MHDs) were stratified by prior preventive medication use\/failure (preventive naive; 0\u20131 failure;\u2009\u2265\u20092 failures). Quality-of-life and economic outcomes were compared among groups using generalized linear modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among individuals with\u2009\u2265\u20094 MHDs (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091106), the NHWS identified 298 (27%) with\u2009\u2265\u20092 failures, 308 (28%) with 0\u20131 failure, and 500 (45%) as preventive naive. Individuals with\u2009\u2265\u20092 failures versus preventive-naive individuals had significantly lower scores on the 12-Item Short Form Survey Physical Component Summary (42.2 vs 44.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.005), numerically higher scores on the Mental Component Summary (39.5 vs 38.5;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.145), significantly higher scores on the Migraine Disability Assessment (39.1 vs 34.0;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05), and significantly higher prevalence of depression symptoms (62% vs 47%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and anxiety symptoms (42% vs 31%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). The\u2009\u2265\u20092 failures group versus the preventive-naive group also had significantly more functional impairment as assessed by mean numbers of migraine-specific missed work days (7.8 vs 4.3) and household activities days (14.3 vs 10.6) in the past 6 months (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) as well as the prevalence of absenteeism (19% vs 13%), overall work impairment (53% vs 42%), and activity impairment (53% vs 47%) (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). Emergency department visits (0.7 vs 0.5;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001) and hospitalizations (0.5 vs 0.3;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) in the past 6 months were significantly higher in the\u2009\u2265\u20092 failures group versus the preventive-naive group, while indirect costs (\u20ac13,720 vs \u20ac11,282) and the proportion of individuals with non-adherence during the past 7 days (73% vs 64%) were numerically higher.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased burden, quality-of-life impairment, and functional impairment exist among individuals with migraine experiencing\u2009\u2265\u20094 MHDs and more treatment failures. While cause and directionality cannot be determined, these results suggest the need for effective preventive migraine treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-023-01655-5","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T19:03:02Z","timestamp":1692817382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impact of headache frequency and preventive medication failure on quality of life, functioning, and costs among individuals with migraine across several European countries: need for effective preventive treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Dawn C.","family":"Buse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pozo-Rosich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Dupont-Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget L.","family":"Balkaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Jauregui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousam","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner LJ, Hagen K, Linde M, Steiner TJ (2022) The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain 23:34","journal-title":"J Headache Pain"},{"key":"1655_CR2","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (2018) The international classification of headache disorders, 3rd edn. Cephalalgia, vol. 38, p 1\u2013211","DOI":"10.1177\/0333102417738202"},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/0333102410381145","volume":"31","author":"AM Blumenfeld","year":"2011","unstructured":"Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A et al (2011) Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 31:301\u2013315","journal-title":"Cephalalgia"},{"key":"1655_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/head.13613","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Fanning KM, Reed ML, Murray S, Dumas PK, Adams AM et al (2019) Life with migraine: effects on relationships, career, and finances from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 59:1286\u20131299","journal-title":"Headache"},{"key":"1655_CR5","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1111\/head.13966","volume":"60","author":"DC Buse","year":"2020","unstructured":"Buse DC, Reed ML, Fanning KM, Bostic RC, Lipton RB (2020) Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American Migraine Prevalence and Prevention (AMPP) study. Headache 60:2340\u20132356","journal-title":"Headache"},{"key":"1655_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/head.14154","volume":"61","author":"R Ishii","year":"2021","unstructured":"Ishii R, Schwedt TJ, Dumkrieger G, Lalvani N, Craven A, Goadsby PJ et al (2021) Chronic versus episodic migraine: the 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. Headache 61:992\u20131003","journal-title":"Headache"},{"key":"1655_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40120-020-00196-2","volume":"9","author":"MJ Doane","year":"2020","unstructured":"Doane MJ, Gupta S, Fang J, Laflamme AK, Vo P (2020) The humanistic and economic burden of migraine in Europe: a cross-sectional survey in five countries. Neurol Ther 9:535\u2013549","journal-title":"Neurol Ther"},{"key":"1655_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","volume":"52","author":"DC Buse","year":"2012","unstructured":"Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC et al (2012) Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention study. Headache 52:1456\u20131470","journal-title":"Headache"},{"key":"1655_CR9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1526-4610.2001.041007638.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF (2001) Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41:638\u2013645","journal-title":"Headache"},{"key":"1655_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"RB Lipton","year":"2007","unstructured":"Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343\u2013349","journal-title":"Neurology"},{"key":"1655_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s10194-020-01208-0","volume":"21","author":"TJ Steiner","year":"2020","unstructured":"Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) Migraine remains second among the world\u2019s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21:137","journal-title":"J Headache Pain"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","volume":"16","author":"Z Katsarava","year":"2012","unstructured":"Katsarava Z, Buse DC, Manack AN, Lipton RB (2012) Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 16:86\u201392","journal-title":"Curr Pain Headache Rep"},{"key":"1655_CR13","unstructured":"World Health Organization. Headache disorders Geneva, Switzerland: World Health Organization; (2016) [April 6, 2016]. Available from: http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/headache-disorders."},{"key":"1655_CR14","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A et al (2021) Migraine: epidemiology and systems of care. Lancet 397:1485\u20131495","journal-title":"Lancet"},{"key":"1655_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0333102416636055","volume":"37","author":"M Torres-Ferr\u00fas","year":"2017","unstructured":"Torres-Ferr\u00fas M, Quintana M, Fernandez-Morales J, Alvarez-Sabin J, Pozo-Rosich P (2017) When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month. Cephalalgia 37:104\u2013113","journal-title":"Cephalalgia"},{"key":"1655_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03331024231189112","volume":"43","author":"A Manack Adams","year":"2023","unstructured":"Manack Adams A, Buse DC, Leroux E, Lanteri-Minet M, Sakai F, Matharu M et al (2023) Chronic Migraine Epidemiology and Outcomes \u2013 International (CaMEO-I) study: methods and multi-country baseline findings for diagnosis rates and care. Cephalalgia 43:1\u201313","journal-title":"Cephalalgia"},{"key":"1655_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.mayocp.2016.02.013","volume":"91","author":"DC Buse","year":"2016","unstructured":"Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A et al (2016) Impact of migraine on the family: perspectives of people with migraine and their spouse\/domestic partner in the CaMEO study. Mayo Clin Proc 91:596\u2013611","journal-title":"Mayo Clin Proc"},{"key":"1655_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s10194-018-0946-z","volume":"19","author":"P Martelletti","year":"2018","unstructured":"Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC et al (2018) My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed. J Headache Pain. 19:115","journal-title":"J Headache Pain."},{"key":"1655_CR19","first-page":"46","volume":"25","author":"JH Ford","year":"2019","unstructured":"Ford JH, Schroeder K, Nyhuis AW, Foster SA, Aurora SK (2019) Cycling through migraine preventive treatments: implications for all-cause total direct costs and disease-specific costs. J Manag Care Spec Pharm 25:46\u201359","journal-title":"J Manag Care Spec Pharm"},{"key":"1655_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s10194-018-0907-6","volume":"19","author":"P Vo","year":"2018","unstructured":"Vo P, Fang J, Bilitou A, Laflamme AK, Gupta S (2018) Patients\u2019 perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom. J Headache Pain 19:82","journal-title":"J Headache Pain"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s40122-021-00331-3","volume":"10","author":"P Pozo-Rosich","year":"2021","unstructured":"Pozo-Rosich P, Lucas C, Watson DPB, Gaul C, Ramsden E, Ritter S et al (2021) Burden of migraine in patients with preventive treatment failure attending European headache specialist centers: real-world evidence from the BECOME study. Pain Ther 10:1691\u20131708","journal-title":"Pain Ther"},{"key":"1655_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40:373\u2013383","journal-title":"J Chronic Dis."},{"key":"1655_CR23","volume-title":"User's Manual for the SF-36v2 Health Survey","author":"ME Maruish","year":"2011","unstructured":"Maruish ME (2011) User\u2019s Manual for the SF-36v2 Health Survey, 3rd edn. Quality Metric Incorporated, Lincoln, RI","edition":"3"},{"key":"1655_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-9-12","volume":"9","author":"A Montazeri","year":"2011","unstructured":"Montazeri A, Vahdaninia M, Mousavi SJ, Asadi-Lari M, Omidvari S, Tavousi M (2011) The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): a population-based validation study from Tehran, Iran. Health Qual Life Outcomes 9:12","journal-title":"Health Qual Life Outcomes"},{"key":"1655_CR25","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D et al (2011) Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20:1727\u20131736","journal-title":"Qual Life Res"},{"key":"1655_CR26","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/WNL.56.suppl_1.S20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Development and testing of the Migraine Disability Assessment (MIDAS) questionnaire to assess headache-related disability. Neurology 56:S20\u2013S28","journal-title":"Neurology"},{"key":"1655_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606\u2013613","journal-title":"J Gen Intern Med"},{"key":"1655_CR28","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, Lowe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097","journal-title":"Arch Intern Med"},{"key":"1655_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2005.11.020","volume":"530","author":"S Gupta","year":"2006","unstructured":"Gupta S, Mehrotra S, Villalon CM, Garrelds IM, de Vries R, van Kats JP et al (2006) Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity. Eur J Pharmacol 530:107\u2013116","journal-title":"Eur J Pharmacol"},{"key":"1655_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353\u2013365","journal-title":"Pharmacoeconomics"},{"key":"1655_CR31","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1185\/03007995.2013.851075","volume":"30","author":"EJ Unni","year":"2014","unstructured":"Unni EJ, Olson JL, Farris KB (2014) Revision and validation of Medication Adherence Reasons Scale (MAR-Scale). Curr Med Res Opin 30:211\u2013221","journal-title":"Curr Med Res Opin"},{"key":"1655_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11136-009-9462-6","volume":"18","author":"SC Bolge","year":"2009","unstructured":"Bolge SC, Doan JF, Kannan H, Baran RW (2009) Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 18:415\u2013422","journal-title":"Qual Life Res"},{"key":"1655_CR33","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/JOM.0b013e318229aae4","volume":"53","author":"EA Finkelstein","year":"2011","unstructured":"Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM (2011) Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J Occup Environ Med 53:1025\u20131029","journal-title":"J Occup Environ Med"},{"key":"1655_CR34","unstructured":"Median hourly earnings, all employees (excluding apprentices) by sex: Eurostat; (2014) [April 8, 2021]. Available from: http:\/\/appsso.eurostat.ec.europa.eu\/nui\/show.do?dataset=earn_ses_pub2s&lang=en."},{"key":"1655_CR35","unstructured":"Stuchlik A. Wage developments in the euro area: European Parliamentary Research Service; (2015) [Available from: https:\/\/www.europarl.europa.eu\/RegData\/etudes\/BRIE\/2015\/565884\/EPRS_BRI(2015)565884_EN.pdf."},{"key":"1655_CR36","volume-title":"Developments in collectively agreed working time 2012","author":"J Cabrita","year":"2013","unstructured":"Cabrita J, Galli da Bino C (2013) Developments in collectively agreed working time 2012. European Foundation for the Improvement of Living and Working Conditions, Dublin, Ireland"},{"key":"1655_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-3999(01)00308-7","volume":"52","author":"SD Foss\u00e5","year":"2002","unstructured":"Foss\u00e5 SD, Dahl AA (2002) Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. J Psychosom Res 52:79\u201387","journal-title":"J Psychosom Res"},{"key":"1655_CR38","volume-title":"SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales","author":"JE Ware","year":"1995","unstructured":"Ware JE, Kosinski M, Keller SD (1995) SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales, 2nd edn. The Health Institute, New England Medical Center, Boston, MA","edition":"2"},{"key":"1655_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s40122-019-0133-1","volume":"8","author":"MJ Doane","year":"2019","unstructured":"Doane MJ, Gupta S, Vo P, Laflamme AK, Fang J (2019) Associations between headache-free days and patient-reported outcomes among migraine patients: a cross-sectional analysis of survey data in Europe. Pain Ther 8:203\u2013216","journal-title":"Pain Ther"},{"key":"1655_CR40","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1111\/ene.14431","volume":"27","author":"P Irimia","year":"2020","unstructured":"Irimia P, Garrido-Cumbrera M, Santos-Lasaosa S, Bra\u00e7e O, Colomina I, Blanch C et al (2020) Estimating the savings associated with a migraine-free life: results from the Spanish Atlas. Eur J Neurol 27:2616\u20132624","journal-title":"Eur J Neurol"},{"key":"1655_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s10194-023-01575-4","volume":"24","author":"M Waliszewska-Pros\u00f3\u0142","year":"2023","unstructured":"Waliszewska-Pros\u00f3\u0142 M, Straburzy\u0144ski M, Czapi\u0144ska-Ciepiela EK, Nowaczewska M, Gryglas-Dworak A, Budrewicz S (2023) Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort: results from \u201cMigraine in Poland\u201d\u2014a nationwide cross-sectional survey. J Headache Pain 24:40","journal-title":"J Headache Pain"},{"key":"1655_CR42","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2147\/COPD.S123744","volume":"12","author":"JB Gruenberger","year":"2017","unstructured":"Gruenberger JB, Vietri J, Keininger DL, Mahler DA (2017) Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis 12:937\u2013944","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1655_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2147\/DMSO.S83696","volume":"8","author":"S Gupta","year":"2015","unstructured":"Gupta S, Richard L, Forsythe A (2015) The humanistic and economic burden associated with increasing body mass index in the EU5. Diabetes Metab Syndr Obes 8:327\u2013338","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1655_CR44","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12888-015-0547-1","volume":"15","author":"S Gupta","year":"2015","unstructured":"Gupta S, Isherwood G, Jones K, Van Impe K (2015) Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BMC Psychiatry 15:162","journal-title":"BMC Psychiatry"},{"key":"1655_CR45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/epi4.12050","volume":"2","author":"S Gupta","year":"2017","unstructured":"Gupta S, Ryvlin P, Faught E, Tsong W, Kwan P (2017) Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil. Epilepsia Open 2:199\u2013213","journal-title":"Epilepsia Open"},{"key":"1655_CR46","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41533-017-0014-1","volume":"27","author":"ID Pavord","year":"2017","unstructured":"Pavord ID, Mathieson N, Scowcroft A, Pedersini R, Isherwood G, Price D (2017) The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting \u03b2(2)-agonists in the United Kingdom: a cross-sectional analysis. NPJ Prim Care Respir Med 27:17","journal-title":"NPJ Prim Care Respir Med"},{"key":"1655_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.chbr.2022.100206","volume":"7","author":"M-J Wu","year":"2022","unstructured":"Wu M-J, Zhao K, Fils-Aime F (2022) Response rates of online surveys in published research: a meta-analysis. Comput Hum Behav Rep 7:100206","journal-title":"Comput Hum Behav Rep"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01655-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01655-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:02:19Z","timestamp":1700388139000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01655-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01655-5","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DCB has received grant support and honoraria from AbbVie, Amgen, Biohaven, Collegium, Eli Lilly and Company, Lundbeck, and Teva and for work on the editorial board of <i>Current Pain and Headache Reports<\/i>. PPR, reports personal fees from AbbVie, Amgen, Biohaven, Chiesi, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, and Teva, and grants paid to her research group from AbbVie, AGAUR, Era-Net Neuron, FEDER RIS3CAT, Instituto Investigaci\u00f3n Carlos III, International Headache Society, Novartis, and Teva. UR, reports support for the present study paid to his institution from AbbVie; grants from BMBF (German Ministry for Research) and Novartis; personal and institutional fees from AbbVie, Allergan, Eli Lilly, Lundbeck, Medscape, Novartis, Pfizer, StreaMedUp, and Teva. BLB, LL, and AJ are employees of Cerner Enviza and received funding from AbbVie to conduct the study. PG, MP, and LDB are employees of AbbVie and may hold AbbVie stock.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}